Document is current
Any future updates will be listed below
-
Authors
Abdallah, Nadine https://orcid.org/0000-0001-9195-1589
Sidana, Surbhi https://orcid.org/0000-0003-3288-7614
Dispenzieri, Angela https://orcid.org/0000-0001-8780-9512
Lacy, Martha
Buadi, Francis
Hayman, Suzanne
Kapoor, Prashant
Leung, Nelson https://orcid.org/0000-0002-5651-1411
Dingli, David
Hwa, Yi Lisa
Lust, John
Russell, Stephen
Gonsalves, Wilson
Go, Ronald
Hogan, William https://orcid.org/0000-0002-5841-4105
Kyle, Robert
Rajkumar, S. Vincent
Gertz, Morie
Kumar, Shaji https://orcid.org/0000-0001-5392-9284
- License Information
-
More Information
Article History
Received: 1 April 2020
Revised: 18 May 2020
Accepted: 28 May 2020
First Online: 9 June 2020
Compliance with ethical standards
:
: S.S. served as a consultant for Janssen. A.D. received research funding from Celgene, Millennium Pharmaceuticals, Pfizer, and Janssen, and received a travel grant from Pfizer. M.G. served as a consultant for Millennium Pharmaceuticals and received honoraria from Celgene, Millennium Pharmaceuticals, Onyx Pharmaceuticals, Novartis, GlaxoSmithKline, Prothena, Ionis Pharmaceuticals, and Amgen. M.L. received research funding from Celgene. N.L. serves on an advisory board for Takeda Pharmaceuticals. S.K. served as a consultant for Celgene, Millennium Pharmaceuticals, Onyx Pharmaceuticals, Janssen, and Bristol-Myers Squibb, and received research funding from Celgene, Millennium Pharmaceuticals, Novartis, Onyx Pharmaceuticals, AbbVie, Janssen, and Bristol-Myers Squibb. The remaining authors declare no competing interests.
